埃克森美孚(XOM.US)出售泰國煉油及零售業務約三分二權益
埃克森美孚(XOM.US)宣布出售埃索泰國66%股權予泰國曼差石油,後者最大股東為泰國政府控股的瓦育帕基金(Vayupak Fund)。
埃索泰國業務包括Sriracha煉油廠,一些分銷油庫及埃索品牌油站。曼差石油在獲得監管機構批准後,將向餘下34%埃索泰國股東提出全購建議。
埃克森美孚將透過成立新公司繼續向泰國供應石油及化學產品,公司的曼谷全球業務中心及當中的約2,000名員工,以及在泰國的勘探與開採業務不受是次出售影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.